Renal Tumor Natural History: the Rationale and Role for Active Surveillance

Urologic Clinics of North America

Volumn 35, Issue 4, 2008, Pages 627-634

  Jewett, Michael A S ^a   Zuniga, Alvaro ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Active surveillance; Kidney tumors; Small renal mass; Watchful waiting

Indexed keywords

ABDOMEN; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER THERAPY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE MANAGEMENT; EARLY DIAGNOSIS; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; IMAGING; INCIDENTAL FINDING; KIDNEY CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THERAPY DELAY; TUMOR BIOPSY; TUMOR GROWTH; TUMOR VOLUME;

BIOPSY; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; HUMANS; KIDNEY NEOPLASMS; NEOPLASM METASTASIS; POPULATION SURVEILLANCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 55249086320     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2008.07.004     Document Type: Review

References (94)

1. Ries LAG, Melbert D, Krapcho M, et al, editors. SEER cancer statistics review, 1975-2004. Bethesda (MD): National Cancer Institute; 2007.
2. Karumanchi S.A., Merchan J., and Sukhatme V.P. Renal cancer: molecular mechanisms and newer therapeutic options. Curr Opin Nephrol Hypertens 11 (2002) 37-42
3. Pantuck A.J., Zisman A., and Belldegrun A.S. The changing natural history of renal cell carcinoma. J Urol 166 (2001) 1611-1623
4. Hollingsworth J.M., Miller D.C., Daignault S., et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98 (2006) 1331-1334
5. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628-1631
6. Hock L.M., Lynch J., and Balaji K.C. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167 (2002) 57-60
7. Tsui K.H., Shvarts O., Smith R.B., et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 163 (2000) 426-430
8. Rendon R.A., Stanietzky N., Panzarella T., et al. The natural history of small renal masses. J Urol 164 (2000) 1143-1147
9. Lee C.T., Katz J., Shi W., et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 163 (2000) 730-736
10. Jayson M., and Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51 (1998) 203-205
11. Luciani L.G., Cestari R., and Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 56 (2000) 58-62
12. Frank I., Blute M.L., Cheville J.C., et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170 (2003) 2217-2220
13. Hollingsworth J.M., Miller D.C., Daignault S., et al. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109 (2007) 1763-1768
14. Mejean A., Vogt B., Quazza J.E., et al. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol 36 (1999) 298-302
15. Stephenson A.J., Hakimi A.A., Snyder M.E., et al. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol 171 (2004) 130-134
16. Uzzo R.G., and Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166 (2001) 6-18
17. Kattan M.W., Reuter V., Motzer R.J., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
18. Licht M.R., Novick A.C., and Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol 152 (1994) 39-42
19. Sutherland S.E., Resnick M.I., Maclennan G.T., et al. Does the sizes of the surgical margin in partial nephrectomy for renal cell cancer really matter?. J Urol 167 (2002) 61-64
20. Wehle M.J., Thiel D.D., Petrou S.P., et al. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 64 (2004) 49-52
21. Fergany A.F., Hafez K.S., and Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163 (2000) 442-445
22. Morgan W.R., and Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended follow-up. J Urol 144 (1990) 852-858
23. Novick A.C. Nephron-sparing surgery for renal cell carcinoma. Br J Urol 82 (1998) 321-324
24. Bosniak M.A., Birnbaum B.A., Krinsky G.A., et al. Small renal parenchymal neoplasms: further observations on growth. Radiology 197 (1995) 589-597
25. Kassouf W., Aprikian A.G., Laplante M., et al. Natural history of renal masses followed expectantly. J Urol 171 (2004) 111-113
26. Oda T., Miyao N., Takahashi A., et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol 8 (2001) 473-477
27. Volpe A., Panzarella T., Rendon R.A., et al. The natural history of incidentally detected small renal masses. Cancer 100 (2004) 738-745
28. Chawla S.N., Crispen P.L., Hanlon A.L., et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006) 425-431
29. Kouba E., Smith A., McRackan D., et al. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177 (2007) 466-470
30. Kunkle D.A., Crispen P.L., Chen D.Y., et al. Enhancing renal masses with zero net growth during active surveillance. J Urol 177 (2007) 849-853
31. Girgin C., Tarhan H., Hekimgil M., et al. P53 mutations and other prognostic factors of renal cell carcinoma. Urol Int 66 (2001) 78-83
32. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27 (2003) 612-624
33. Kato M., Suzuki T., Suzuki Y., et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 172 (2004) 863-866
34. Sowery R.D., and Siemens D.R. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 11 (2004) 2407-2410
35. Lamb G.W., Bromwich E.J., Vasey P., et al. Management of renal masses in patients medically unsuitable for nephrectomy-natural history, complications, and outcome. Urology 64 (2004) 909-913
36. Corica F.A., Iczkowski K.A., Cheng L., et al. Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol 161 (1999) 408-411
37. Koga S., Nishikido M., Hayashi T., et al. Outcome of surgery in cystic renal cell carcinoma. Urology 56 (2000) 67-70
38. Nassir A., Jollimore J., Gupta R., et al. Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature. Urology 60 (2002) 421-427
39. Bretheau D., Lechevallier E., Eghazarian C., et al. Prognostic significance of incidental renal cell carcinoma. Eur Urol 27 (1995) 319-323
40. Sweeney J.P., Thornhill J.A., Graiger R., et al. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. Br J Urol 78 (1996) 351-353
41. Thompson I.M., and Peek M. Improvement in survival of patients with renal cell carcinoma-the role of the serendipitously detected tumor. J Urol 140 (1988) 487-490
42. Delahunt B., Bethwaite P.B., Thornton A., et al. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome. Cancer 75 (1995) 2714-2719
43. Fujimoto N., Sugita A., Terasawa Y., et al. Observations on the growth rate of renal cell carcinoma. Int J Urol 2 (1995) 71-76
44. Kim H.L., Seligson D., Liu X., et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173 (2005) 1496-1501
45. Oda T., Takahashi A., Miyao N., et al. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma. Int J Urol 10 (2003) 13-18
46. Pantuck A.J., Seligson D.B., Klatte T., et al. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer 109 (2007) 2257-2267
47. Phuoc N.B., Ehara H., Gotoh T., et al. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Urology 69 (2007) 843-848
48. Shin Lee J., Seok Kim H., Bok Kim Y., et al. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. J Surg Oncol 84 (2003) 166-172
49. Zhang X., and Takenaka I. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma. Urology 56 (2000) 510-515
50. Dimaras H., and Gallie B.L. The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development. Int J Cancer 122 (2008) 2023-2029
51. Dimaras H., Khetan V., Halliday W., et al. Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 10 (2008) 1363-1372
52. Higgins J.P., Shinghal R., Gill H., et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 162 (2003) 925-932
53. Hirata H., Hinoda Y., Matsuyama H., et al. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun 342 (2006) 1058-1062
54. Jones J., Otu H., Spentzos D., et al. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 11 (2005) 5730-5739
55. Kosari F., Parker A.S., Kube D.M., et al. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 11 (2005) 5128-5139
56. Sultmann H., von Heydebreck A., Huber W., et al. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival. Clin Cancer Res 11 (2005) 646-655
57. Takahashi M., Rhodes D.R., Furge K.A., et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 98 (2001) 9754-9759
58. Vasselli J.R., Shih J.H., Iyengar S.R., et al. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A 100 (2003) 6958-6963
59. Zhao H., Ljungberg B., Grankvist K., et al. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 3 (2006) e13
60. Crispen P.L., and Uzzo R.G. The natural history of untreated renal masses. BJU Int 99 (2007) 1203-1207
61. Lane B.R., Samplaski M.K., Herts B.R., et al. Renal mass biopsy-a renaissance?. J Urol 179 (2008) 20-27
62. Volpe A., Kachura J.R., Geddie W.R., et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178 (2007) 379-386
63. Khan A.A., Shergill I.S., Quereshi S., et al. Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol 7 (2007) 10
64. Campbell S.C., Novick A.C., Herts B., et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology 50 (1997) 25-29
65. Beland M.D., Mayo-Smith W.W., Dupuy D.E., et al. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate?. AJR Am J Roentgenol 188 (2007) 792-797
66. Maturen K.E., Nghiem H.V., Caoili E.M., et al. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 188 (2007) 563-570
67. Wunderlich H., Hindermann W., Al Mustafa A.M., et al. The accuracy of 250 fine needle biopsies of renal tumors. J Urol 174 (2005) 44-46
68. Brierly R.D., Thomas P.J., Harrison N.W., et al. Evaluation of fine-needle aspiration cytology for renal masses. BJU Int 85 (2000) 14-18
69. Eshed I., Elias S., and Sidi A.A. Diagnostic value of CT-guided biopsy of indeterminate renal masses. Clin Radiol 59 (2004) 262-267
70. Hara I., Miyake H., Hara S., et al. Role of percutaneous image-guided biopsy in the evaluation of renal masses. Urol Int 67 (2001) 199-202
71. Lechevallier E., Andre M., Barriol D., et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216 (2000) 506-510
72. Neuzillet Y., Lechevallier E., Andre M., et al. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol 171 (2004) 1802-1805
73. Richter F., Kasabian N.G., Irwin Jr. R.J., et al. Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies. Urology 55 (2000) 348-352
74. Vasudevan A., Davies R.J., Shannon B.A., et al. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int 97 (2006) 946-949
75. Abe M., and Saitoh M. Selective renal tumour biopsy under ultrasonic guidance. Br J Urol 70 (1992) 7-11
76. Auvert J., Abbou C.C., and Lavarenne V. Needle tract seeding following puncture of renal oncocytoma. Prog Clin Biol Res 100 (1982) 597-598
77. Gibbons R.P., Bush Jr. W.H., and Burnett L.L. Needle tract seeding following aspiration of renal cell carcinoma. J Urol 118 (1977) 865-867
78. Herts B.R., and Baker M.E. The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol 13 (1995) 254-261
79. Kiser G.C., Totonchy M., and Barry J.M. Needle tract seeding after percutaneous renal adenocarcinoma aspiration. J Urol 136 (1986) 1292-1293
80. Shenoy P.D., Lakhkar B.N., Ghosh M.K., et al. Cutaneous seeding of renal carcinoma by Chiba needle aspiration biopsy. Case report. Acta Radiol 32 (1991) 50-52
81. Wehle M.J., and Grabstald H. Contraindications to needle aspiration of a solid renal mass: tumor dissemination by renal needle aspiration. J Urol 136 (1986) 446-448
82. Smith E.H. Complications of percutaneous abdominal fine-needle biopsy. Radiology 178 (1991) 253-258 [review]
83. Cristallini E.G., Paganelli C., and Bolis G.B. Role of fine-needle aspiration biopsy in the assessment of renal masses. Diagn Cytopathol 7 (1991) 32-35
84. Juul N., Torp-Pedersen S., Gronvall S., et al. Ultrasonically guided fine needle aspiration biopsy of renal masses. J Urol 133 (1985) 579-581
85. Niceforo J., and Coughlin B.F. Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy. AJR Am J Roentgenol 161 (1993) 1303-1305
86. Rybicki F.J., Shu K.M., Cibas E.S., et al. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol 180 (2003) 1281-1287
87. Renshaw A.A., Lee K.R., Madge R., et al. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. Acta Cytol 41 (1997) 987-994
88. Cajulis R.S., Katz R.L., Dekmezian R., et al. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol 37 (1993) 367-372
89. Wood B.J., Khan M.A., McGovern F., et al. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol 161 (1999) 1470-1474
90. Silverman S.G., Deuson T.E., Kane N., et al. Percutaneous abdominal biopsy: cost-identification analysis. Radiology 206 (1998) 429-435
91. Frank I., Blute M.L., Cheville J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
92. Walther M.M., Choyke P.L., Glenn G., et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161 (1999) 1475-1479
93. Zisman A., Pantuck A.J., Chao D., et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm better correlates with clinical outcome. J Urol 166 (2001) 54-58
94. Mattar K, Basiuk J, Finelli A, et al. Active surveillance of small renal masses: a prospective multi-centre Canadian trial. Presented at the Annual EAU Congress, Milan, Italy. March 26-29, 2008.